Company Analysis
Sign in

Indivior Pharmaceuticals, Inc. (INDV)

Nasdaq: INDV · Pharmaceutical Preparations · North Chesterfield, VA · filing with the SEC since 2014
Full chart Alerts Compare
Grade6.8
◀ Past 8.4● Present 6.8▶ Future 5.3
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

37 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Indivior Pharmaceuticals, Inc.’s names, not what it holds today.

Patents granted
37
37 utility, 1976 to Dec 31, 2025
Granted in 2025
2
Against 1 in 2024 and 2 in 2023
Applications published
49
5 of them in 2025
Names they are printed under
4
a subsidiary, a former name
By yearGrantedApplications published
'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals8
Medical technology2
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
Indivior UK Limited a subsidiary
GB, as the owner printed on each patent
37 granted
6 published
Indivior UK Limited a subsidiary
named as the applicant on its applications, in GB
0 granted
41 published
Indivior Inc. a former name
US, as the owner printed on each patent
0 granted
1 published
Indivior Inc. a former name
named as the applicant on its applications, in US
0 granted
1 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Oct 14, 202512,441,709Therapeutic compoundsPharmaceuticalsIndivior UK Limited
May 6, 202512,290,596Compositions and methods for the treatment of opioid overdosePharmaceuticalsIndivior UK Limited
Jan 2, 202411,857,498Syringe systemMedical technologyIndivior UK Limited
Dec 12, 202311,839,611Buprenorphine dosing regimensPharmaceuticalsIndivior UK Limited
Aug 1, 202311,712,475Sustained delivery formulations of risperidone compoundPharmaceuticalsIndivior UK Limited
Oct 25, 202211,478,407Syringe systemMedical technologyIndivior UK Limited
Oct 5, 202111,135,216Sublingual and buccal film compositionsPharmaceuticalsIndivior UK Limited
Sep 7, 202111,110,093Sustained release small molecule drug formulationPharmaceuticalsIndivior UK Limited
May 25, 202111,013,809Sustained delivery formulations of risperidone compoundPharmaceuticalsIndivior UK Limited
May 11, 202111,000,520Buprenorphine dosing regimensPharmaceuticalsIndivior UK Limited
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Nov 20, 20252025/0352522RAPID INDUCTION WITH MONTHLY INJECTABLE BUPRENORPHINE EXTENDED-RELEASEPharmaceuticalsIndivior UK Limited
Aug 14, 20252025/0255861METHODS FOR ADMINISTERING BUPRENORPHINEPharmaceuticalsIndivior UK Limited
Jul 3, 20252025/0213553BUPRENORPHINE DOSING REGIMENSPharmaceuticalsIndivior UK Limited
Apr 24, 20252025/0127765RAPID INDUCTION WITH MONTHLY INJECTABLE BUPRENORPHINE EXTENDED-RELEASEPharmaceuticalsIndivior UK Limited
Apr 24, 20252025/0127712COMPOSITIONS AND METHODS FOR THE TREATMENT OF OPIOID OVERDOSEPharmaceuticalsIndivior Inc.
Dec 12, 20242024/0408004COMPOSITIONS, DEVICES, AND METHODS FOR THE TREATMENT OF OVERDOSE AND REWARD-BASED DISORDERSPharmaceuticalsIndivior UK Limited
Dec 12, 20242024/0408003COMPOSITIONS, DEVICES AND METHODS FOR THE TREATMENT OF ALCOHOL USE DISORDERPharmaceuticalsIndivior UK Limited
Jun 20, 20242024/0197719FORMULATIONS AND METHODS FOR THE PREVENTION OF OPIOID OVERDOSEPharmaceuticalsIndivior Inc.
May 18, 20232023/0149262SYRINGE SYSTEMMedical technologyIndivior UK Limited · patent 11,857,498 granted from it
May 4, 20232023/0135427SUSTAINED DELIVERY FORMULATIONS OF RISPERIDONE COMPOUNDPharmaceuticalsIndivior UK Limited
What it applied for, 2024 to 2025: Pharmaceuticals 8.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton INDV · research, not advice